Comments
Natco Pharma on Wednesday launched a generic version of Teriflunomide for the treatment of relapsing and remitting forms of multiple sclerosis (RRMS), under its brand Denopsy.
This is the first oral medicine for RRMS being offered in India in 14 mg and 7 mg tablets. Teriflunomide is sold by Sanofi-Genzyme under the brand name Aubagio, in the US. The number of patients suffering from multiple sclerosis in India is 5-20 per one lakh population.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.